Meanwhile, SIRT6 may positively mediate glucose-stimulated insulin secretion [44] and overexpression of it enhances insulin sensitivity in skeletal muscle and liver, emerging as an attractive therapeutic target for T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.